MEMORANDUM OF UNDERSTANDING UCREST BERHAD ("UCREST" OR "THE COMPANY") MEMORANDUM OF UNDERSTANDING ("MOU") WITH RUSSIAN DIRECT INVESTMENT FUND ("RDIF") - MASTER SERVICE AGREEMENT BETWEEN ITS WHOLLY OWNED SUBSIDIARY, UCREST TECHNOLOGY LIMITED AND WITH LIMITED LIABILITY COMPANY "HUMAN VACCINE ("HUMAN VACCINE"), A WHOLLY OWNED SUBSIDIARY OF RDIF
| UCREST BERHAD |
| Type | Announcement |
| Subject | MEMORANDUM OF UNDERSTANDING |
| Description | UCREST BERHAD ("UCREST" OR "THE COMPANY")
MEMORANDUM OF UNDERSTANDING ("MOU") WITH RUSSIAN DIRECT INVESTMENT FUND ("RDIF")
- MASTER SERVICE AGREEMENT BETWEEN ITS WHOLLY OWNED SUBSIDIARY, UCREST TECHNOLOGY LIMITED AND WITH LIMITED LIABILITY COMPANY "HUMAN VACCINE ("HUMAN VACCINE"), A WHOLLY OWNED SUBSIDIARY OF RDIF |
|
Further to the announcements made by the Company on the Memorandum of Understanding (“MOU”) between Company and Russian Direct Investment Fund (“RDIF”) on 9 April 2021, 14 April 2021, 28 April 2021, 19 May 2021, 20 May 2021 and 9 June 2021, the Board of Directors of UCrest (“Board”) is pleased to announce that its wholly owned subsidiary, UCrest Technology Limited ("UTL") had on 6 September 2021 entered into a Master Service Agreement with Limited Liability Company "Human Vaccine" ("Human Vaccine"), a wholly owned subsidiary of RDIF for production of Sputnik V Vaccines (“Vaccine” or “Products”), following the MOU signed between their respective parent companies, UCrest and RDIF in April 2021.
Futher details of the Master Service Agreement are set out in the attachment below.
This announcement is dated 6 September 2021. |
|
Please refer attachment below.
Announcement Info
| Company Name | UCREST BERHAD |
| Stock Name | UCREST |
| Date Announced | 06 Sep 2021 |
| Category | General Announcement for PLC |
| Reference Number | GA1-06092021-00023 |